Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty

Abstract

The presence of obesity increases the risk of thrombotic vascular diseases. The role of fat accumulation and its effect on plasminogen activator inhibitor–1 (PAI–1) levels was investigated in humans and animals. Plasma PAI–1 levels were closely correlated with visceral fat area but not with subcutaneous fat area in human subjects. PAI–1 mRNA was detected in both types of fat tissue in obese rats but increased only in visceral fat during the development of obesity. These data suggest that an enhanced expression of the PAI–1 gene in visceral fat may increase plasma levels and may have a role in the development of vascular disease in visceral obesity.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Larsson, B. et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br. Med. J. 288, 1401–1404 (1984).

    CAS  Article  Google Scholar 

  2. Kissebah, A.H. et al. Relation of body fat distribution to metabolic complications of obesity. J. clin. Endocrinol. Metab. 54, 254–260 (1982).

    CAS  Article  Google Scholar 

  3. Deprés, J.P. et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38, 304–309 (1989).

    Article  Google Scholar 

  4. Matsuzawa, Y., Tokunaga, K., Fujioka, S. & Tarui, S. Pathophysiology of visceral fat obesity. in Progress in Obesity Research, (ed. Oomura, Y.) 309–312 (John Libbey, London, 1990).

    Google Scholar 

  5. Nakamura, T. et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107, 239–246 (1994).

    CAS  Article  Google Scholar 

  6. Wiman, B. & Hamsten, A. The fibrinolytic enzyme system and its role in the etiology of thrombo-embolic disease. J. Biol. Chem. 259, 3644–3647 (1984).

    CAS  PubMed  Google Scholar 

  7. Hamsten, A., Wiman, B., Faire, U.D. & Blomback, M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313, 1557–1563 (1985).

    CAS  Article  Google Scholar 

  8. Wiman, B. & Hamsten, A. The fibrinolytic enzyme system and its role in the etiology of thrombotic disease. Semin. Thromb. Haemost. 26, 207–216 (1990).

    Article  Google Scholar 

  9. Auwerx, J., Bouillon, R., Collen, D. & Geboers, J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8, 68–72 (1988).

    CAS  Article  Google Scholar 

  10. Vague, P. et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35, 250–253 (1986).

    CAS  Article  Google Scholar 

  11. Lucore, C.L., Fujii, S., Wun, T.C., Sobel, B.E. & Billadello, J.J. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J. Biol. Chem. 263, 15845–15848 (1988).

    CAS  PubMed  Google Scholar 

  12. Kooistra, T. et al. Plasminogen activator inhibitor 1: Biosynthesis and mRNA levels are increased by insulin in cultured human hepatocytes. Thromb. Haemost. 62, 723–728 (1989).

    CAS  PubMed  Google Scholar 

  13. Hotamisligil, G.S., Shargili, N.S. & Spiegelman, B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).

    CAS  Article  Google Scholar 

  14. Hotamisiigil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J. Clin. Invest. 95, 2409–2415 (1995).

    Article  Google Scholar 

  15. Spiegelman, B.M., Choy, L.:., Hotamisligil, G.S., Graves, R.A. & Tontonoz, P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268, 6823–6826 (1993).

    CAS  PubMed  Google Scholar 

  16. Ailhaud, G., Grimaldi, P. & Negrel, R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12, 207–233 (1992).

    CAS  Article  Google Scholar 

  17. Shimomura, I. et al. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am. J. Physiol. 265, E44E50 (1993).

    CAS  Article  Google Scholar 

  18. Björntorp, P. “portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 10, 493–496 (1990).

    Article  Google Scholar 

  19. Reaven, G.M. Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988).

    CAS  Article  Google Scholar 

  20. Tokunaga, K., Matsuzawa, Y., Ishikawa, K. & Tarui, S. A novel technique for the determination of fat by computed tomography. Int. J. Obes. 7, 437–445 (1983).

    CAS  PubMed  Google Scholar 

  21. Fujioka, S., Matsuzawa, Y., Tokunaga, K. & Tarui, S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36, 54–59 (1987).

    CAS  Article  Google Scholar 

  22. Tokunaga, K., Fukushima, M., Kemnitz, J.W. & Bray, G.A. Comparison of ven-tromedial and paraventricular lesions in rats that become obese. Am. J. Physiol. 251, R1221–R1227 (1986).

    CAS  PubMed  Google Scholar 

  23. Funahashi, T. et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem. Biophys. Res. Commun. 211, 469–475 (1995).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shimomura, I., Funahasm, T., Takahashi, M. et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty. Nat Med 2, 800–803 (1996). https://doi.org/10.1038/nm0796-800

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0796-800

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing